A robotic-assisted therapy that uses an ultrasound-guided heat-free waterjet could become the standard of care for treating benign prostatic hyperplasia, or BPH, according to two sets of data presented at the American Urological Association (AUA) annual meeting last weekend in San Antonio, TX.
San Jose, CA-based PROCEPT BioRobotics device firm says that its Aquablation therapy is the first and only treatment that features...